The global market for pharmaceutical-grade Fusidic Acid witnessed a sustained price uptrend in August 2025, building on momentum from July. This surge is attributed to a confluence of market-driving factors, including seasonal demand spikes due to humid weather conditions that have tripled the incidence of skin and eye infections, particularly conjunctivitis. Strategic pricing by suppliers, coupled with cautious inventory management by buyers during Q2, created a supply-demand imbalance. Downstream sectors such as pharmaceuticals, dermatology, and ophthalmology saw heightened offtake, pushing prices upward. With limited stock from previous production cycles and new procurement lagging behind demand, the market responded with notable price adjustments across key regions.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
